Transcranial magnetic stimulation participants for Healthy Subjects
This trial tests how brain activity changes when doing hard tasks and when exposed to magnetic stimulation.
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Are individuals currently able to participate in this experiment?
"The data published on clinicaltrials.gov indicates that this trial is actively searching for patients to participate in it. It was initially posted on April 1st 2023, and the latest version of the study was up-to-date as of March 31st 2023."
Does this experimental program encompass individuals older than 25 years old?
"According to the inclusion criteria, participants must range between 18 and 45 years of age. For minors, there are 54 separate trials while those over 65 can access 369 different studies."
What are the eligibility requirements to participate in this research?
"To be considered eligible for this trial, aspiring participants must fit the criteria of healthy individuals aged 18-45 years old. 30 volunteers are required to complete the experiment."
What is the participant pool size for this clinical examination?
"Affirmative. According to the information available on clinicaltrials.gov, recruitment for this medical study is ongoing; it was initially posted in April 1st 2023 and lastly updated on March 31st of the same year. A total of thirty individuals are needed from one site alone."
What objectives does this clinical trial hope to accomplish?
"This trial's primary aims are to measure the immediate effects of target stimulation and gauge participants' functional excitation-inhibition balance (E/I Balance) 20 minutes before their first transcranial magnetic stimulation session. Secondary objectives include quantifying how prolonged target or sham stimulations impact E/I balances, with a focus on assessing any protracted recovery following either type of treatment."